Fred G Behm
Overview
Explore the profile of Fred G Behm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
1124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dreyer Z, Hilden J, Jones T, Devidas M, Winick N, Willman C, et al.
Pediatr Blood Cancer
. 2014 Nov;
62(3):419-26.
PMID: 25399948
Background: Infants with acute lymphoblastic leukemia (ALL) present with aggressive disease and a poor prognosis. Early relapse within 6-9 months of diagnosis is common. Approximately 75% of infants have MLL-rearranged...
2.
Hijiya N, Hudson M, Lensing S, Zacher M, Onciu M, Behm F, et al.
JAMA
. 2007 Mar;
297(11):1207-15.
PMID: 17374815
Context: Little is known about the incidence of secondary neoplasms after 15 to 20 years in children and adolescents who were treated for acute lymphoblastic leukemia. Objectives: To investigate the...
3.
Kung F, Schwartz C, Ferree C, London W, Ternberg J, Behm F, et al.
J Pediatr Hematol Oncol
. 2006 Jun;
28(6):362-8.
PMID: 16794504
To determine if 6 courses of chemotherapy alone could achieve the same or better outcome than 4 courses of chemotherapy followed by radiation therapy (chemoradiotherapy) in pediatric and adolescent patients...
4.
Becton D, Dahl G, Ravindranath Y, Chang M, Behm F, Raimondi S, et al.
Blood
. 2005 Oct;
107(4):1315-24.
PMID: 16254147
Relapse is a major obstacle in the cure of acute myeloid leukemia (AML). The Pediatric Oncology Group AML Study 9421 tested 2 different strategies to improve event-free survival (EFS) and...
5.
Hijiya N, Onciu M, Howard S, Zhang Z, Cheng C, Sandlund J, et al.
Cancer
. 2004 Nov;
101(11):2681-6.
PMID: 15517573
Background: Absolute neutrophil counts (ANCs) and absolute phagocyte counts (APCs) are used to guide cancer treatment. Although automated counting could replace manual counting, data showing correlations are lacking. By analyzing...
6.
Mathew S, Shurtleff S, Ribeiro R, Behm F, Raimondi S
Leuk Lymphoma
. 2003 Apr;
44(1):183-7.
PMID: 12691161
Although the classic t(8;21) has been reported in 10 pediatric patients with acute myeloid leukemia with eosinophilia (AML M4Eo), no complex variant t(8;21) in children with AML M4Eo has been...
7.
Crews K, Gandhi V, Srivastava D, Razzouk B, Tong X, Behm F, et al.
J Clin Oncol
. 2002 Oct;
20(20):4217-24.
PMID: 12377965
Purpose: To identify the optimal schedule for infusion of cytarabine (ara-C) given with cladribine (2-CdA) to pediatric patients with acute myeloid leukemia (AML), and to compare the effects of the...
8.
Ferrando A, Neuberg D, Staunton J, Loh M, Huard C, Raimondi S, et al.
Cancer Cell
. 2002 Jun;
1(1):75-87.
PMID: 12086890
Human T cell leukemias can arise from oncogenes activated by specific chromosomal translocations involving the T cell receptor genes. Here we show that five different T cell oncogenes (HOX11, TAL1,...
9.
Ross M, Shurtleff S, Williams W, Patel D, Mahfouz R, Behm F, et al.
Cancer Cell
. 2002 Jun;
1(2):133-43.
PMID: 12086872
Treatment of pediatric acute lymphoblastic leukemia (ALL) is based on the concept of tailoring the intensity of therapy to a patient's risk of relapse. To determine whether gene expression profiling...